• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-world evidence for preventive effects of statins on cancer incidence: A trans-Atlantic analysis.

作者信息

Gohlke Bjoern-O, Zincke Fabian, Eckert Andreas, Kobelt Dennis, Preissner Saskia, Liebeskind Juliane Maria, Gunkel Nikolas, Putzker Kerstin, Lewis Joe, Preissner Sally, Kortüm Benedikt, Walther Wolfgang, Mura Cameron, Bourne Philip E, Stein Ulrike, Preissner Robert

机构信息

Department of Information Technology, Science-IT, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.

出版信息

Clin Transl Med. 2022 Feb;12(2):e726. doi: 10.1002/ctm2.726.

DOI:10.1002/ctm2.726
PMID:35184411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8858616/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba5/8858616/812548d2af0b/CTM2-12-e726-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba5/8858616/fbb8352644c4/CTM2-12-e726-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba5/8858616/679daf779549/CTM2-12-e726-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba5/8858616/8b3d327f078f/CTM2-12-e726-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba5/8858616/812548d2af0b/CTM2-12-e726-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba5/8858616/fbb8352644c4/CTM2-12-e726-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba5/8858616/679daf779549/CTM2-12-e726-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba5/8858616/8b3d327f078f/CTM2-12-e726-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba5/8858616/812548d2af0b/CTM2-12-e726-g001.jpg

相似文献

1
Real-world evidence for preventive effects of statins on cancer incidence: A trans-Atlantic analysis.他汀类药物对癌症发病率预防作用的真实世界证据：一项跨大西洋分析。
Clin Transl Med. 2022 Feb;12(2):e726. doi: 10.1002/ctm2.726.
2
The role of statins in cancer prevention and treatment.他汀类药物在癌症预防和治疗中的作用。
Oncology (Williston Park). 2005 May;19(6):739-50; discussion 753-4.
3
Novel prospects of statins as therapeutic agents in cancer.他汀类药物作为癌症治疗药物的新前景。
Pharmacol Res. 2014 Oct;88:84-98. doi: 10.1016/j.phrs.2014.06.013. Epub 2014 Jul 5.
4
Statins and cancer: current and future prospects.他汀类药物与癌症：现状与未来前景。
Cancer Lett. 2012 Nov 1;324(1):1-12. doi: 10.1016/j.canlet.2012.04.011. Epub 2012 Apr 24.
5
A clinical review of statins and cancer: helpful or harmful?他汀类药物与癌症的临床研究：有益还是有害？
Pharmacotherapy. 2010 Feb;30(2):177-94. doi: 10.1592/phco.30.2.177.
6
Statins: do they have a potential role in cancer prevention and modifying cancer-related outcomes?他汀类药物：它们在癌症预防和改变与癌症相关的结局方面有潜在作用吗？
Drugs. 2014 Oct;74(16):1841-1848. doi: 10.1007/s40265-014-0309-2.
7
Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?他汀类药物对癌症的保护作用：高危患者是否应使用？
Curr Atheroscler Rep. 2016 Dec;18(12):72. doi: 10.1007/s11883-016-0625-y.
8
Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.他汀类药物和法尼基转移酶抑制剂对癌症发生发展的影响。
Cancer Treat Rev. 2004 Nov;30(7):609-41. doi: 10.1016/j.ctrv.2004.06.010.
9
Pharmacological actions of statins: a critical appraisal in the management of cancer.他汀类药物的药理作用：癌症治疗中的批判性评价。
Pharmacol Rev. 2012 Jan;64(1):102-46. doi: 10.1124/pr.111.004994. Epub 2011 Nov 21.
10
The role of statins in cancer therapy.他汀类药物在癌症治疗中的作用。
Oncologist. 2006 Mar;11(3):306-15. doi: 10.1634/theoncologist.11-3-306.

引用本文的文献

1
Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.他汀类药物降低代谢功能障碍相关脂肪性肝病患者肝细胞癌的风险：一项系统评价和荟萃分析。
World J Exp Med. 2024 Dec 20;14(4):98543. doi: 10.5493/wjem.v14.i4.98543.
2
MACC1 revisited - an in-depth review of a master of metastasis.重新审视MACC1——对转移“大师”的深入回顾
Biomark Res. 2024 Nov 23;12(1):146. doi: 10.1186/s40364-024-00689-4.
3
Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy.

本文引用的文献

1
Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis.他汀类药物的使用可降低肝细胞癌的发病率：一项更新的荟萃分析。
Cancers (Basel). 2020 Apr 3;12(4):874. doi: 10.3390/cancers12040874.
2
Statin uses and mortality in colorectal cancer patients: An updated systematic review and meta-analysis.他汀类药物在结直肠癌患者中的使用与死亡率：一项更新的系统评价和荟萃分析。
Cancer Med. 2019 Jun;8(6):3305-3313. doi: 10.1002/cam4.2151. Epub 2019 May 8.
3
MACC1-the first decade of a key metastasis molecule from gene discovery to clinical translation.
代谢介质：微生物衍生代谢物作为抗肿瘤免疫、免疫疗法和化疗的关键调节剂。
Front Immunol. 2024 Sep 16;15:1456030. doi: 10.3389/fimmu.2024.1456030. eCollection 2024.
4
Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling.抑制3-羟基-3-甲基戊二酰辅酶A还原酶通过刺猬信号通路抑制肝细胞癌的干性和转移。
Genes Dis. 2024 Apr 3;11(5):101285. doi: 10.1016/j.gendis.2024.101285. eCollection 2024 Sep.
5
Immune Response and Metastasis-Links between the Metastasis Driver MACC1 and Cancer Immune Escape Strategies.免疫反应与转移——转移驱动因子MACC1与癌症免疫逃逸策略之间的联系
Cancers (Basel). 2024 Mar 28;16(7):1330. doi: 10.3390/cancers16071330.
6
Pre-operative levels of angiopoietin protein-like 3 (ANGPTL3) in women diagnosed with high-grade serous carcinoma of the ovary.术前女性高级别浆液性卵巢癌中血管生成素样蛋白 3（ANGPTL3）的水平。
Lipids Health Dis. 2024 Feb 27;23(1):59. doi: 10.1186/s12944-024-02038-8.
7
MACC1 Regulates LGR5 to Promote Cancer Stem Cell Properties in Colorectal Cancer.MACC1通过调控LGR5促进结直肠癌中癌症干细胞特性
Cancers (Basel). 2024 Jan 31;16(3):604. doi: 10.3390/cancers16030604.
8
Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer.表型异质性导致三阴性乳腺癌小鼠模型中不同的疾病结局。
Front Oncol. 2023 Sep 29;13:1230647. doi: 10.3389/fonc.2023.1230647. eCollection 2023.
9
Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to Deafness.结直肠癌转移相关蛋白1（MACC1）mRNA表达在散发性前庭神经鞘瘤中增强并与耳聋相关。
Cancers (Basel). 2023 Aug 14;15(16):4089. doi: 10.3390/cancers15164089.
10
Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures.髓外多发性骨髓瘤患者骨髓和血浆的蛋白质组学与代谢组学分析确定了独特的蛋白质和代谢物特征。
Cancers (Basel). 2023 Jul 25;15(15):3764. doi: 10.3390/cancers15153764.
MACC1-从基因发现到临床转化的关键转移分子的第一个十年。
Cancer Metastasis Rev. 2018 Dec;37(4):805-820. doi: 10.1007/s10555-018-9771-8.
4
Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1.他汀类药物和rottlerin小分子抑制剂通过MACC1限制结肠癌的进展和转移。
PLoS Biol. 2017 Jun 1;15(6):e2000784. doi: 10.1371/journal.pbio.2000784. eCollection 2017 Jun.
5
Statin Use After Diagnosis of Colon Cancer and Patient Survival.结肠癌诊断后使用他汀类药物与患者生存。
Gastroenterology. 2017 Aug;153(2):470-479.e4. doi: 10.1053/j.gastro.2017.05.011. Epub 2017 May 13.
6
Emerging Biological Principles of Metastasis.转移的新兴生物学原理
Cell. 2017 Feb 9;168(4):670-691. doi: 10.1016/j.cell.2016.11.037.
7
Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study.解析他汀类药物、胆固醇与结直肠癌之间的关联：一项巢式病例对照研究。
PLoS Med. 2016 Apr 26;13(4):e1002007. doi: 10.1371/journal.pmed.1002007. eCollection 2016 Apr.
8
Statin use and reduced cancer-related mortality.他汀类药物的使用与降低癌症相关死亡率。
N Engl J Med. 2012 Nov 8;367(19):1792-802. doi: 10.1056/NEJMoa1201735.
9
MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.MACC1是新发现的HGF-MET信号通路关键调节因子，可预测结肠癌转移。
Nat Med. 2009 Jan;15(1):59-67. doi: 10.1038/nm.1889. Epub 2008 Dec 21.
10
Statins and the risk of colorectal cancer.他汀类药物与结直肠癌风险
N Engl J Med. 2005 May 26;352(21):2184-92. doi: 10.1056/NEJMoa043792.